lojuxta 20 mg
medison pharma ltd - lomitapide as mesylate - capsules - lomitapide as mesylate 20 mg - lomitapide - an adjunct to a low-fat diet and other lipid-lowering treatments, including ldl apheresis where available, to reduce low-density lipoprotein cholesterol (ldl-c), total cholesterol (tc), apolipoprotein b (apo b), and non-high-density lipoprotein cholesterol (non-hdl-c) in patients with homozygous familial hypercholesterolemia (hofh).
lojuxta 5 mg
medison pharma ltd - lomitapide as mesylate - capsules - lomitapide as mesylate 5 mg - lomitapide - an adjunct to a low-fat diet and other lipid-lowering treatments, including ldl apheresis where available, to reduce low-density lipoprotein cholesterol (ldl-c), total cholesterol (tc), apolipoprotein b (apo b), and non-high-density lipoprotein cholesterol (non-hdl-c) in patients with homozygous familial hypercholesterolemia (hofh).
miprosed 5mg/ml oral solution
syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - midazolam - oral solution - midazolam 5 mg/ml - psycholeptics
midazolam 5 mg/ml solution for injection/infusion
as kalceks - midazolam - solution for injection/infusion - 5 milligram(s)/millilitre - midazolam
ozalin 2 mg/ml oral solution in single-dose container
primex pharmaceuticals oy - midazolam - oral solution in single-dose container - 2 milligram(s)/millilitre - midazolam
midazolam 1 mg/ml solution for injection/infusion
as kalceks - midazolam - solution for injection/infusion - 1 milligram(s)/millilitre - midazolam
mictonorm uno 30 mg hartkapseln mit veränderter wirkstofffreisetzung hartkapsel mit veränderter wirkstofffreisetzung
propinorm uno 30 mg hartkapseln mit veränderter wirkstofffreisetzung